Tech.Sight.Tech.Sight.Tech.Sight.Tech.Sight.Tech.Sight.Tech.Sight.Tech.Sight.Sight.Tech.Sight.Tech.Sight.Sight.Tech.S
Kelly K Hunt1, Stephan A Vorburger
1Department of Surgical Oncology, The University of Texas M. D. Anderson Cancer Center, Houston, TX 77030, USA. khunt@mdanderson.org
Science (New York, N.Y.)
|July 20, 2002
まとめ
遺伝子療法は,がん治療において有望であり,現在500以上の臨床試験が進行中である. 重要な課題には,遺伝子配送の改善,腫瘍標的化,およびより良いがん遺伝子治療の結果のための毒性の減少が含まれています.
科学分野:
- 腫瘍学 腫瘍学
- 分子生物学は分子生物学である.
- バイオテクノロジー バイオテクノロジー
背景:
- 遺伝子療法は,過去10年間で著しい進歩を遂げ,500以上の遺伝子療法のプロトコルが臨床試験に参入しています.
- 進歩にもかかわらず,臨床試験は,効果的ながん遺伝子治療のために対処する必要があるいくつかの障害を明らかにしました.
研究 の 目的:
- 癌の遺伝子治療の進歩のための重要な分野を概説する.
- 遺伝子配送,腫瘍標的化,治療ウィンドウを改善するための戦略について議論する.
- 遺伝子療法を,より広範ながん治療の分野における補完的なアプローチとして位置づけること.
主な方法:
- 改善された遺伝子配送のための新しいベクトルの開発に焦点を当てます.
- 精密ながん標的化のための腫瘍選択的結合剤の研究.
- 治療ウィンドウを最適化し,組み合わせ療法における毒性を最小限に抑えるための戦略.
主要な成果:
- 現在の遺伝子療法の臨床試験における主要な課題を特定する.
- 改善されたベクター,ターゲティングメカニズム,毒性管理の必要性を強調する.
- 遺伝子治療と従来の治療の統合を強調する.
結論:
- 癌の遺伝子治療は,ベクトル発育,腫瘍特異性,および安全性プロファイルに関するさらなる研究を必要とします.
- 遺伝子療法は,既存のがん治療の代替ではなく,補足として見るべきです.
- 目標は,合理的で分子的に導かれた遺伝子治療のアプローチで治療兵器を強化することです.
関連する概念動画
02:18Cancer
Cancers arise due to mutations in genes involved in the regulation of cell division, which leads to unrestricted cell proliferation. Modern science and medicine have made great strides in the understanding and treatment of cancer, including eradicating cancer in some patients. However, there is still no cure for cancer. This is largely due to the fact that cancer is a large group of many diseases.
02:49Cancer Therapies
Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
02:57Targeted Cancer Therapies
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...
There are several types of targeted therapies against specific...
02:56Treatment Resistant Cancers
Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
02:49Cancer Therapies
Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
02:56Treatment Resistent Cancers
Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...